Winton Group LTD Cytokinetics Inc Transaction History
Winton Group LTD
- $1.35 Billion
- Q4 2024
A detailed history of Winton Group LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Winton Group LTD holds 19,005 shares of CYTK stock, worth $756,589. This represents 0.07% of its overall portfolio holdings.
Number of Shares
19,005
Previous 9,795
94.03%
Holding current value
$756,589
Previous $517,000
72.73%
% of portfolio
0.07%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding CYTK
# of Institutions
401Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$584 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$474 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$428 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$246 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$113 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.75B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...